Revance Therapeutics Inc. (rvnc 1.75 02/15/27)
13F holders, Q1 2024 (March 31)1holders
$0.73avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Revance Therapeutics Inc. (rvnc 1.75 02/15/27) in their 13F filings. The largest holder was Sonora Investment Management Group, LLC ($2.2M).
- Company
- Revance Therapeutics Inc. (rvnc 1.75 02/15/27)
- CUSIP
- 761330AB5
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Sonora Investment Management Group, LLC | 0.18% | Reduce -0.5% | 3,035,000 | $2.2M |
"% of holder's portfolio" is REVANCE THERAPEUTICS INC (RVNC 1.75 02/15/27)'s weight in each manager's 13F, not the share of Revance Therapeutics Inc. (rvnc 1.75 02/15/27) the manager owns.